United States· US:68382-396_6ad04728-e1b6-4851-9614-1322607ce238
SODIUM PHENYLACETATE AND SODIUM BENZOATE
A medicinal product containing sodium phenylacetate; sodium benzoate, registered in United States by Zydus Pharmaceuticals USA Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- SODIUM PHENYLACETATE; SODIUM BENZOATE
- Manufacturer
- Zydus Pharmaceuticals USA Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1168382-396-01
- ndc1168382396011 VIAL in 1 CARTON (68382-396-01) / 50 mL in 1 VIAL
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cdd41b7f-ebae-40da-9590-831471882273 GET /v1/drugs/cdd41b7f-ebae-40da-9590-831471882273?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "100; 100",
"substance": "SODIUM PHENYLACETATE; SODIUM BENZOATE",
"productndc": "68382-396",
"dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
"dea_schedule": null,
"strength_unit": "mg/mL; mg/mL",
"application_number": "ANDA205880",
"marketing_category": "ANDA"
}See everything about sodium phenylacetate; sodium benzoate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.